AzTrials
AzTrials

Major Depressive DisordersTVi-OpenNCT02309060

Storytelling Video Intervention for Depressed Primary Care Patients - Open Trial

A study testing Storytelling Video Intervention (sTVi) in people with Major Depressive Disorder, run by Butler Hospital at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overall aim of this program of research is to develop a collaborative narrative intervention for patients with depression being treated in primary care. The purpose of the proposed project is to establish the feasibility, acceptability, and preliminary effects of our newly developed narrative intervention on… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Major Depressive Disorder
What is being tested?
Storytelling Video Intervention (sTVi)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
11 participants
Where
2 sitesUnited States
Study dates
Sep 2016to 1 Mar 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Meets DSM-5 criteria for current or lifetime major depressive disorder.
  • No Lifetime diagnosis of bipolar disorder, schizophrenia, or chronic psychotic condition.
  • No current hazardous illicit drug or alcohol use.
  • No suicidal ideation or behavior requiring immediate attention.
  • Depression symptom severity: a Quick Inventory of Depressive Symptoms (QIDS) score >11.
  • Taking an antidepressant medication for at least 6 weeks; prescribed by their primary care provider.
Show all 11Show fewer
  • Not in psychotherapy during the study period.
  • Have a PCP at our enrollment site.
  • If pregnant, less than 24 weeks gestation.
  • English speaking.
  • Aged 18 or older.

Who cannot join

None listed.

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Family Care Center of Memorial Hospital

    Pawtucket, Rhode Island, 02860

  • Butler Hospital

    Providence, Rhode Island, 02906

Other trials in United States

About this study

Official title: Narrative Intervention to Disseminate ACT for Depression in Primary Care

The overall aim of this program of research is to develop a collaborative narrative intervention for patients with depression being treated in primary care.

The purpose of the proposed project is to establish the feasibility, acceptability, and preliminary effects of our newly developed narrative intervention on depression.

To achieve the specific aims, the investigators will conduct an open trial to further develop and refine the intervention (n = 10).

Read the detailed description

The public health impact of existing treatments for major depression is limited by our ability to disseminate those treatments. There is a particular need to find innovative ways to disseminate key principles of empirically supported psychotherapy in primary care settings. Narrative communication is an alternative way to disseminate psychotherapy behavior change principles. Narrative communication refers to "storytelling" -real people talking about their struggles and successful ways of coping. An advantage of narrative communication is that it can be easily distributed (by video) and may reach people who do not have access to other technologies or who experience barriers to traditional psychotherapy. We propose that key principles of a type of cognitive-behavioral therapy (Acceptance and Commitment Therapy, or ACT) can be readily disseminated through a video storytelling intervention. ACT is an empirically supported therapy for depression. Together with a video production firm with a record of working in healthcare and developing documentary-style videos, we will produce a storytelling video intervention (sTVi).

Our aim is to conduct a small open trial (n = 10) of antidepressant medication treatment as usual + sTVi. Assessments will occur at baseline and 4 weeks (post-treatment). We will examine the feasibility and acceptability of sTVi (e.g., uptake and completion of sTVi, engagement with videos, and understanding of key ACT principles) and of this research design. We will examine treatment effects (within relevant confidence intervals) on outcomes (e.g., depression severity). We will examine change in potential mechanisms, i.e., ACT-consistent coping strategies derived from key ACT principles.

Being tested
Storytelling Video Intervention (sTVi)
Keywords
narrative communication, depression, primary care, treatment development
Medical subject headings
Depressive Disorder, Major, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Storytelling Video Intervention (sTVi)Behavioural

    Narrative communication, video-based intervention for depressed primary care patients.

Study groups in NCT02309060
Study groupRoleWhat they receive
Storytelling Video Intervention (sTVi)ExperimentalWe will develop a series of 4 videos, each episode approximately 30 minutes long, which will illustrate the key principles of Acceptance and Commitment Therapy. We will add a short, non-narrative, epilogue at the end of each of the 4 episodes that summarizes key messages and provides information on identifying signs of depression and suggestions for efficacious treatments. In addition, we will develop an accompanying "personal journal" for participants that includes a brief self-help guide which encourages participants to write about what they learned in the videos and how they will take similar steps in their own lives to cope with depression.
Receives: Behavioral: Storytelling Video Intervention (sTVi)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Client Satisfaction Questionnaire-8 (CSQ-8)

    Measured: 4 weeks

Secondary outcomes (2)
  1. Quick Inventory of Depressive Symptomatology-Clinician Rating (QIDS-C)

    Measured: 4 weeks

  2. Acceptance and Action Questionnaire-II (AAQ-II)

    Measured: 4 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2014 (estimated)
  2. Study startSep 2016
  3. Primary completionFeb 2017
  4. Study completion1 Mar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
11 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02309060
Sponsor's protocol ID
sTVi-1
Other IDs
R34MH103568
Acronym
sTVi-Open
Status last verified
Jun 2019
First submitted
3 Dec 2014
Last updated
25 Jun 2019
Results posted
No
Data monitoring committee
No

Publications

  • Gaudiano BA, Davis CH, Miller IW, Uebelacker LA. Development of a Storytelling Video Self-Help Intervention Based on Acceptance and Commitment Therapy for Major Depression: Open Trial Results. Behav Modif. 2019 Jan;43(1):56-81. doi: 10.1177/0145445517738932. Epub 2017 Nov 1.

    PubMed 29090593

Questions about this trial

What is this clinical trial studying?

A study testing Storytelling Video Intervention (sTVi) in people with Major Depressive Disorder, run by Butler Hospital at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Client Satisfaction Questionnaire-8 (CSQ-8) (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02309060, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in